Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Zhifei Biological completes RMB1.4bn IPO on Shenzhen Exchange

Executive Summary

Chinese vaccines company Chongqing Zhifei Biological Products Co. Ltd. (Zhifei) has completed a 40mm-share IPO priced at RMB37.98 ($5.71), netting RMB1.43bn ($215mm). The company listed on the Shenzhen Exchange's Growth Enterprise Market (GEM) index.
Deal Industry
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

Advertisement
UsernamePublicRestriction

Register